A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
about
A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traitsEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerGenomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskOvarian cancer screening--current status, future directionsGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskFAK in cancer: mechanistic findings and clinical applicationsGenetic risk prediction in complex diseaseDNA methylation changes in epithelial ovarian cancer histotypes.Targeted immune therapy of ovarian cancerMutations in BRIP1 confer high risk of ovarian cancerContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationClinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusA Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal CancerHOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptomeThree new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Ovarian cancer epidemiology in the era of collaborative team science.Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data.Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis.Prediction of potential cancer-risk regions based on transcriptome data: towards a comprehensive viewA programmable method for massively parallel targeted sequencing.Functional annotation signatures of disease susceptibility loci improve SNP association analysis.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.Genetic variants within the cancer susceptibility region 8q24 and ovarian cancer risk in Han Chinese womenMethylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans
P2860
Q24169696-22402A2D-83C5-4B62-978E-42B449F083C8Q24633316-D8DFB969-AAA7-48A2-A708-C400B4BB5008Q26740622-4A050476-0A5A-4B75-9C2F-28612F1F3B81Q26799669-C1130E73-E2E2-42CD-AD79-05E3380CC52EQ27004471-4C04B386-96CA-4636-87E7-DEDB5D7D9241Q27008356-0ACC3C45-DFB7-4991-B5C6-07B201474240Q27026533-27C0F003-A845-4959-8FCE-521C94C0CA01Q27027720-E28DAEE7-BE03-432E-BDF9-625D4D1F25C6Q27690722-86BCA0A4-1937-4251-A4C0-74C51F260377Q28082828-47BA952E-E7F4-486C-A0F9-CC9D507A2C07Q28249514-FCB4AD0A-7786-4B06-8E6F-2BF7493246A3Q28266112-BFD9FD40-A36F-4D1C-B01D-AA8BF86F3E5EQ28307436-DC1AA714-6B45-4D26-B059-FEBF605FED04Q28384141-99D47A22-5A1E-4D96-8893-3E4B70E0C333Q28396029-0EFC3EE7-86F7-4ADF-A72C-233589D9D366Q28652372-14D7F3F3-50FD-473C-8358-1E5800D5BDC8Q29248193-3CF35C91-F6C4-4661-A322-9A9EC72B97FAQ29248527-10176127-F957-44A4-944D-5F329130DF37Q29416989-8F1A7F04-6CED-40C4-81CF-53957FA7E58CQ30252854-00C8494D-B3D2-4F9A-B022-471D4279F994Q30252952-E559D303-311F-4463-B859-B61E2247309BQ30252987-0845EDD0-412E-45C6-82CF-2C8762CD13BAQ30275132-61A52353-6762-477A-B89E-F85753A9506AQ30276359-42215396-6333-446F-8F9B-3B010EE8D12DQ30276986-927098FF-0D39-40B7-BC6E-45C203AB93AAQ30277151-49EFB3FB-6960-41D5-8F24-40ACB9CB0792Q30277784-D2CB5A87-670D-4805-9EA7-5654490A4786Q30374367-FAA3A4C3-2B31-4175-8E99-C064D9373B8FQ30430198-49D5F70C-FC3E-4186-8F95-AF3A272482BCQ30573020-A8742DB6-6980-43A1-A72A-6E7188014ECBQ30635212-0244472C-7C44-44E2-A235-9BC96CDA70F7Q33567947-382B5131-5740-4D58-9B89-0A46106E3FE2Q33698641-5EE41BE3-BBAC-4706-8253-0F56C96E6FF4Q33701048-31AA2D86-18FE-4B67-B467-71CDD9AD79DEQ33778612-DA63E91A-39DF-4E55-A24E-623F37320664Q33810288-62FCAF60-9663-4DD3-BE0D-5E36EF94A5EBQ33810401-0025594C-C76F-49D8-B850-5EE48E7FEBA1Q33829530-9670EC23-F98D-4AE7-9E8A-8F29639BB559Q33915396-EA7AA761-0174-451E-82A4-938D79823F55Q33921139-88BFC6A6-271C-428B-BB4E-8E3960E6842C
P2860
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@ast
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@en
type
label
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@ast
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@en
prefLabel
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@ast
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@en
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
A genome-wide association stud ...... arian cancer at 2q31 and 8q24.
@en
P2093
Alice S Whittemore
Andrew Berchuck
Andrew K Godwin
Anne M van Altena
Anne Stafford
Arto Leminen
Ashley N Molina
Australian Cancer Study (Ovarian Cancer)
P2860
P2888
P304
P3181
P356
10.1038/NG.668
P407
P50
P5008
P577
2010-09-19T00:00:00Z
P5875
P6179
1049362151